Back to search

Belgium· BE-AMP-SAM335273-00

Otrivine Duo 0.5 mg/ml - 0.6 mg/ml

A xylometazoline product containing ipratropium bromide, registered in Belgium by Haleon Belgium. The same ATC class is registered in 10 of our 19 countries.

ATC R01AB06

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedOtrivine Duo 0.5 mg/ml - 0.6 mg/mlATCR01AB06REGISTER NO.BE-AMP-SAM335273-00PACKS LISTED1CHECKEDSeptember 26, 2026

Where it is registered

Xylometazoline is registered in 10 of 19 countries.

Countries holding a registration under ATC R01AB06 (xylometazoline), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose

Xylometazoline · ATC R01AB06

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Ipratropium Bromide
Manufacturer
Haleon Belgium
Country
Belgium (BE)
ATC code
R01AB06
ATC class
Xylometazoline
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    4902045

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

63 interactions on record for xylometazoline.

Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Xylometazoline · interactions on record

63 records

  • 6 severe
  • 54 moderate

Most severe, free to view

  • MethylergometrineG02AB01severe
  • DihydroergotamineN02CA01severe
  • ErgotamineN02CA02severe
  • MethysergideN02CA04severe

3 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Xylometazoline in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All xylometazoline products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Atrovent - Dosieraerosol, Ipratropiumbromid Infectopharm
  • Cyprus · Atrovent
  • Czechia · Atrovent, Atrovent N
  • Germany · Atrovent, Atrovent Ls
  • Denmark · Atrovent, Ipratropiumbromid Teva
  • Estonia · Atrovent N
  • Spain · Atroaldo, Atrovent
  • Finland · Atrovent, Atrovent Eco
  • France · Atrovent, Atrovent Adultes
  • United Kingdom (Northern Ireland) · Atrovent Inhaler Cfc-Free, Atrovent Udvs
  • Greece · Atrovent, Broncovent
  • Croatia · Atrovent, Atrovent N
  • Hungary · Atrovent N
  • Ireland · Atrovent 250 Udvs, Atrovent 500 Udvs
  • Iceland · Atrovent, Lomuspray
  • Italy · Atem, Nasipral
  • Lithuania · Atrovent N
  • Luxembourg · Atrovent, Atrovent Hfa
  • Malta · Atroaldo, Atrovent Inhaler Cfc-Free
  • Netherlands · Atrovent, Atrovent Unit Dose
  • Norway · Atrovent, Ipraxa
  • Poland · Atrodil, Atrovent
  • Portugal · Atrovent, Atrovent Pa
  • Romania · Ipravent Inhaler
  • Sweden · Atrovent, Ipravent
  • Slovakia · Atrovent N

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fa3f19d4-3c9f-4637-8818-3016115a5d26
GET /v1/drugs/fa3f19d4-3c9f-4637-8818-3016115a5d26?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Nasal spray, solution",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Otrivine Duo 0.5 mg/ml - 0.6 mg/ml",
  "name_fr": "Otrivine Duo 0.5 mg/ml - 0.6 mg/ml",
  "name_nl": "Otrivine Duo 0.5 mg/ml - 0.6 mg/ml",
  "amp_code": "SAM335273-00",
  "strengths": [
    "0.6000",
    "0.6000",
    "0.5000",
    "0.5000",
    "0.5000",
    "27.9000"
  ],
  "pack_count": 1,
  "substances": [
    "Ipratropium Bromide",
    "Xylometazoline Hydrochloride",
    "Disodium Edetate",
    "Glycerol",
    "Sodium Hydroxide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Xylometazoline",
  "authorisation_numbers": [
    "BE335273"
  ]
}

See everything about xylometazoline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.